Marshall Wace, LLP Celldex Therapeutics, Inc. Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

A detailed history of Marshall Wace, LLP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 276,728 shares of CLDX stock, worth $6.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
276,728
Previous 1,377,868 79.92%
Holding current value
$6.52 Million
Previous $51 Million 81.57%
% of portfolio
0.01%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$32.06 - $44.56 $35.3 Million - $49.1 Million
-1,101,140 Reduced 79.92%
276,728 $9.4 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $15.7 Million - $20.4 Million
479,068 Added 53.3%
1,377,868 $51 Million
Q1 2024

May 15, 2024
SELL
$35.22 - $51.88 $13.4 Million - $19.8 Million
-381,284 Reduced 29.79%
898,800 $37.7 Million
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $16.8 Million - $30.2 Million
741,765 Added 137.79%
1,280,084 $50.8 Million
Q3 2023

Nov 14, 2023
BUY
$25.45 - $37.46 $6.33 Million - $9.32 Million
248,796 Added 85.93%
538,319 $14.8 Million
Q2 2023

Aug 14, 2023
SELL
$30.29 - $38.28 $1.34 Million - $1.69 Million
-44,143 Reduced 13.23%
289,523 $9.82 Million
Q1 2023

May 15, 2023
SELL
$34.78 - $47.43 $11.6 Million - $15.8 Million
-333,083 Reduced 49.96%
333,666 $12 Million
Q4 2022

Feb 14, 2023
BUY
$27.78 - $45.38 $389,697 - $636,590
14,028 Added 2.15%
666,749 $29.7 Million
Q3 2022

Nov 14, 2022
BUY
$22.7 - $37.57 $14.4 Million - $23.8 Million
632,698 Added 3159.86%
652,721 $18.3 Million
Q2 2022

Aug 15, 2022
BUY
$20.5 - $37.33 $410,471 - $747,458
20,023 New
20,023 $539,000
Q2 2021

Aug 13, 2021
SELL
$20.71 - $35.37 $426,211 - $727,914
-20,580 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$16.19 - $29.91 $138,537 - $255,939
8,557 Added 71.17%
20,580 $423,000
Q4 2020

Feb 16, 2021
BUY
$14.99 - $22.75 $180,224 - $273,523
12,023 New
12,023 $211,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.1B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email